Nomogram for the diagnosis of suspected papillary thyroid carcinomas based on sonographic patterns: a retrospective study.

Li Liang, Jinhui Xie, Shulan Li, Jie Yang, Dongdong Chen, Nan Wang, Zubang Zhou
Author Information
  1. Li Liang: Department of Ultrasound, Gansu Provincial Hospital, Lanzhou 730000, China.
  2. Jinhui Xie: Department of Ultrasound, Gansu Provincial Hospital, Lanzhou 730000, China.
  3. Shulan Li: Department of Ultrasound, Gansu Provincial Hospital, Lanzhou 730000, China.
  4. Jie Yang: Department of Ultrasound, Gansu Provincial Hospital, Lanzhou 730000, China.
  5. Dongdong Chen: Department of thyroid surgery, Gansu Provincial Hospital, Lanzhou 730000, China.
  6. Nan Wang: Department of Ultrasound, Gansu Provincial Hospital, Lanzhou 730000, China.
  7. Zubang Zhou: Department of Ultrasound, Gansu Provincial Hospital, Lanzhou 730000, China.

Abstract

BACKGROUND: High resolution ultrasonography (US) is the first choice for diagnosis of thyroid cancer and is based on many sonographic features: composition, echogenicity, margins, calcifications, shape and vascularity. Here, we tried to develop a nomogram to evaluate papillary thyroid carcinoma (PTC) based on sonographic features.
METHODS: From Aug 2016 to Dec 2017, a primary cohort of 382 patients with suspicious thyroid nodules and accepted US examinations were included in Gansu Provincial Hospital. Sonographic features were used to develop a nomogram with Cox regression analysis. The nomogram was validated using prospective data from 162 patients as the validation group.
RESULTS: The primary and validation cohort showed comparable clinical and US features in all aspects. Univariate and multivariate analyses showed solid composition [odds ratio (OR): 3.785; 95% confidence interval (CI): 1.504-9.528, P=0.005], hypoechoic (OR: 15.840; 95% CI: 5.754-43.602, P<0.001) and irregular margins (OR: 15.953; 95% CI: 5.897-43.160, P<0.001), microcalcifications (OR: 21.730; 95% CI: 7.119-66.329, P<0.001), taller than wide shape (OR: 5.153; 95% CI: 1.997-13.311, P=0.001), internal high vascularization (OR: 6.288; 95% CI: 2.175-18.181, P=0.001), and obscure borders (OR: 5.648; 95% CI: 2.118-15.065, P=0.001) as risk factors for PTC. Based on the seven risk factors, nomogram was developed and validated by a prospective group, and discrimination and calibration were measured using the concordance index (C-index).
CONCLUSIONS: Our novel nomogram risk score model based on the US features accurately predicted PTC nodule diagnosis.

Keywords

References

  1. AJR Am J Roentgenol. 2002 Mar;178(3):687-91 [PMID: 11856699]
  2. Clin Radiol. 2007 Mar;62(3):245-51 [PMID: 17293218]
  3. AJNR Am J Neuroradiol. 2008 Mar;29(3):563-8 [PMID: 18039755]
  4. Radiology. 2008 Jun;247(3):762-70 [PMID: 18403624]
  5. J Clin Endocrinol Metab. 2009 May;94(5):1748-51 [PMID: 19276237]
  6. Eur J Clin Invest. 2009 Aug;39(8):699-706 [PMID: 19601965]
  7. Thyroid. 2009 Nov;19(11):1257-64 [PMID: 19754280]
  8. Am J Clin Pathol. 2009 Nov;132(5):658-65 [PMID: 19846805]
  9. Radiology. 2011 Sep;260(3):892-9 [PMID: 21771959]
  10. J Radiol. 2011 Jul-Aug;92(7-8):701-13 [PMID: 21819912]
  11. J Clin Endocrinol Metab. 2012 Mar;97(3):905-13 [PMID: 22170709]
  12. J Clin Endocrinol Metab. 2013 Feb;98(2):564-70 [PMID: 23275525]
  13. J Clin Oncol. 2013 Mar 20;31(9):1188-95 [PMID: 23358969]
  14. Head Neck. 2016 Feb;38(2):309-15 [PMID: 25244250]
  15. Nat Rev Endocrinol. 2014 Dec;10(12):707-8 [PMID: 25331285]
  16. Ann Surg. 2015 Aug;262(2):321-30 [PMID: 25361221]
  17. Pancreas. 2015 Apr;44(3):459-64 [PMID: 25423557]
  18. Thyroid. 2016 Jan;26(1):1-133 [PMID: 26462967]
  19. J Ultrasound Med. 2015 Dec;34(12):2179-85 [PMID: 26507699]
  20. Pol J Radiol. 2016 Apr 08;81:152-6 [PMID: 27103947]
  21. Braz J Otorhinolaryngol. 2017 Jan - Feb;83(1):73-79 [PMID: 27161187]
  22. Eur J Cancer. 2016 Jul;62:86-95 [PMID: 27232330]
  23. Oncotarget. 2017 May 23;8(21):35311-35325 [PMID: 27852049]
  24. Ultrasonography. 2017 Apr;36(2):103-110 [PMID: 28222584]
  25. Sci Rep. 2017 Mar 09;7:43928 [PMID: 28276466]
  26. Nat Rev Endocrinol. 2017 Jul;13(7):415-424 [PMID: 28361927]
  27. Oncotarget. 2017 Jun 6;8(23):37208-37216 [PMID: 28388538]
  28. Nat Commun. 2017 Jun 05;8:15533 [PMID: 28580939]
  29. Lancet Oncol. 2019 Feb;20(2):193-201 [PMID: 30583848]

Word Cloud

Created with Highcharts 10.0.095%nomogramOR:CI:001USthyroidbasedPTCfeaturesP=05diagnosissonographicP<0riskultrasonographycompositionmarginsshapedeveloppapillarycarcinomaprimarycohortpatientsvalidatedusingprospectivevalidationgroupshowed:1152factorsBACKGROUND:Highresolutionfirstchoicecancermanyfeatures:echogenicitycalcificationsvascularitytriedevaluateMETHODS:Aug2016Dec2017382suspiciousnodulesacceptedexaminationsincludedGansuProvincialHospitalSonographicusedCoxregressionanalysisdata162RESULTS:comparableclinicalaspectsUnivariatemultivariateanalysessolid[oddsratioOR3785confidenceintervalCI504-9528005]hypoechoic840754-43602irregular953897-43160microcalcifications217307119-66329tallerwide153997-13311internalhighvascularization6288175-18181obscureborders648118-15065BasedsevendevelopeddiscriminationcalibrationmeasuredconcordanceindexC-indexCONCLUSIONS:novelscoremodelaccuratelypredictednoduleNomogramsuspectedcarcinomaspatterns:retrospectivestudyPapillary

Similar Articles

Cited By